Articles

Theratechnologies déposera la demande d’approbation de Trogarzo(MC) (ibalizumab) en Europe

Invesco Ltd. : Form 8.3 - Shire PLC

Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET

Diaxonhit, acteur incontournable du diagnostic in vitro et des sciences de la vie: Résultats annuels 2017

Shire plc : Holding(s) in Company

CAC40 ..tasse avec anse ..haussier

Investorideas.com - Cobalt and Nickel: Two Essential Elements for EVs

helios..(HMNY)

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets

Årsredovisning 2017 Active Biotech AB (publ)